Medicus Pharma earnings were -$51.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MDCX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$9.0M, down 40% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MDCX reported annual earnings of -$47.3M, with 323.8% growth. The next MDCX earnings date is Aug 10, 2026.
Medicus Pharma (NASDAQ: MDCX) reported Q1 2026 earnings per share (EPS) of -$0.31, up 26.19% year over year. Total MDCX earnings for the quarter were -$9.04 million. In the same quarter last year, Medicus Pharma's earnings per share (EPS) was -$0.42.
The next MDCX earnings date is Invalid Date. Add MDCX to your watchlist to be reminded of Medicus Pharma's next earnings date.
Is Medicus Pharma profitable or losing money?
As of the last Medicus Pharma earnings report, Medicus Pharma is currently losing money. Medicus Pharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$39.38 million, a 170.67% increase year over year.
What was MDCX's earnings growth in the past year?
As of Medicus Pharma's earnings date in Q3 2026, Medicus Pharma's earnings has grown year over year. MDCX earnings in the past year totalled -$51.22 million.
What are Medicus Pharma's earnings expectations?
The current EPS estimate for Medicus Pharma's earnings report in Invalid Date is -$0.14.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.